Moderna loses less than expected as Covid vaccine sales beat estimates, cost cuts take hold - CNBC

The company reiterated its full-year 2024 sales guidance of roughly $4 billion, which includes revenue from the expected launch of its RSV vaccine.

Thursday's analyst calls: Discount retailers upgraded, more good news for Carvana, tough outlook for CVS - CNBC

This is CNBC Pro's live coverage of Thursday's analyst calls and Wall Street chatter.

Novo Nordisk Hikes Guidance as Weight-Loss Drug Sales Surge. The Stock Is Falling. - Barron's

Tesla's 'full self-driving' remains unfinished. I found out first-hand - USA TODAY

Amazon, Target and other retailers pull weighted infant sleepwear over safety fears - NPR

Federal regulators, medical experts and safe-sleep advocates have warned of the potential danger of weighted infant sleepwear, but manufacturers say their products have helped millions of families.

Stock futures rise after Fed decides to hold rates steady: Live updates - CNBC

Wednesday was choppy on Wall Street as traders studied the latest Fed decision and Chair Jerome Powell's press conference.

Apple to report Q2 earnings amid iPhone slowdown, China troubles - Yahoo Finance

U.S. v. Google: As landmark 'monopoly power' trial closes, here's what to look for - NPR

Is Google an illegal monopoly that's thwarted rivals to remain on top or is it simply a beloved search engine? Now it's up to the judge to decide.